Veelen A, Andriessen C, Op den Kamp Y, Erazo-Tapia E, et al. Effects of the sodium-glucose cotransporter 2 inhibitor dapagliflozin on substrate metabolism in prediabetic insulin resistant individuals: A randomized, double-blind crossover trial. Metabolism 2023;140:155396.
PMID: 36592688